← Open Payments lookup

MARK DAVIS: Open Payments

NPI 1265296412 · WALLA WALLA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,361 in 41 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $1,130 · 2025 $1,361

Food & beverage: $1,361
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$345
Neurocrine BioSciences, Inc.6$255
E.R. Squibb & Sons, L.L.C.7$214
Janssen Pharmaceuticals, Inc7$196
Axsome Therapeutics, Inc.3$160
Supernus Pharmaceuticals, Inc.3$131
Teva Pharmaceuticals USA, Inc.2$46
Otsuka America Pharmaceutical, Inc.1$15

Products named: CAPLYTA, INGREZZA, COBENFY, INVEGA SUSTENNA, Auvelity, Qelbree, UZEDY, REXULTI.

Industry payments across WA — which companies pay providers there.